USPTO serial 97698996
IONIQ HEALTH
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- NADEAU, MADELINE JEAN
- Law office
- TMEG LAW OFFICE 104
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IONIQ HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Portland, OR, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ERNEST G. BOOTSMA
ERNEST G. BOOTSMA BUCHALTER, A PROFESSIONAL CORPORATION805 S.W. Broadway, Suite 1500Portland, OR 97205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management, business administration, marketing and promotion of pharmacies and infusion centers for patients with particular medical conditions; coordination and support of the delivery of pharmacy and infusion services, namely, arranging managed care services in the fields of durable medical equipment and specialty pharmacy supplies; pharmaceutical cost management services for others, namely, business data reporting and analytics to others in the field of drug utilization review; business administration services, namely, coordination of prescription medication fulfillment to pharmacies to establish pharmacy networks for health care providers, patients, and members for controlling drug inventories | ACTIVE | — |
| 036 | Pharmaceutical and medical benefit management services; reimbursement payment processing in the fields of pharmaceutical and medical claims; providing financial information relating to drug pricing and actuarial services to others; pharmacy network management in the nature of monitoring financial performance of pharmacies for the purpose of measuring and reporting on the cost of pharmaceutical and medical networks to others | ACTIVE | — |
| 042 | Drug utilization review in the nature of providing medical research information for educating about proper medication utilization to medical, pharmaceutical, and dental providers, patients and members; medical research in the fields of drug utilization review for drug interactions, duplication of drug therapy, contraindications; medical research in the field of drug utilization review in the nature of drug interactions and contraindications | ACTIVE | — |
| 044 | Clinical pharmacy services for pharmacy and infusion therapy patients with certain medical conditions; pharmacy advice and counseling for pharmacy and infusion therapy patients; preparation of prescriptions in pharmacy and infusion centers, hospitals and medical clinics; medication therapy management services for individuals in the nature of checking medication compliance and medication counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 12, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 11, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 10, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 6, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 26, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 26, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 26, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 27, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 1, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 1, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 26, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2022 | NWAP | NEW APPLICATION ENTERED | — |